(Q67906918)
Statements
A phase II study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer. The North Thames Ovary Group (English)
A Phase II study of ondansetron as antiemetic prophylaxis in patients receiving carboplatin for advanced ovarian cancer (English)
D. B. Smith
G. J. Rustin
N. Howells
H. E. Lambert
1 September 1991